Bayesian Capital Management’s CME Group CME Stock Holding History

Bayesian Capital Management’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.66M	Buy	+7,500	New	+$2.07M	1.06%	17
2025 Q1	–	Sell	-1,800	Closed	-$418K	–	660
2024 Q4	$418K	Buy	+1,800	New	+$414K	0.05%	408
2024 Q1	–	Sell	-7,218	Closed	-$1.52M	–	819
2023 Q4	$1.52M	Buy	+7,218	New	+$1.54M	0.16%	162
2023 Q1	–	Sell	-18,520	Closed	-$3.11M	–	829
2022 Q4	$3.11M	Buy	18,520 +13,000	+236%	+$2.26M	0.46%	24
2022 Q3	$978K	Buy	+5,520	New	+$1.09M	0.2%	137
2021 Q3	–	Sell	-2,169	Closed	-$461K	–	405
2021 Q2	$461K	Buy	+2,169	New	+$458K	0.12%	203
2020 Q1	–	Sell	-1,300	Closed	-$261K	–	797
2019 Q4	$261K	Buy	+1,300	New	+$267K	0.04%	464
2019 Q1	–	Sell	-1,558	Closed	-$293K	–	579
2018 Q4	$293K	Buy	+1,558	New	+$288K	0.06%	418
2018 Q3	–	Sell	-1,625	Closed	-$266K	–	644
2018 Q2	$266K	Buy	1,625 +303	+23%	+$49.5K	0.06%	441
2018 Q1	$214K	Buy	+1,322	New	+$210K	0.05%	485

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bayesian Capital Management's CME Position: Q2 2026 in Review

Bayesian Capital Management opened a new position in CME Group (CME) in Q2 2026: 7,500 shares worth $1.66M. The stake represents 1.06% of the portfolio and ranks #17 among its holdings. This is a return to the name: Bayesian Capital Management previously reported a position in CME as recently as Q4 2024.

Bayesian Capital Management first reported a position in CME in Q1 2018 and has held it in 10 quarters since. The position peaked at $3.11M in Q4 2022. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Bayesian Capital Management held 7,500 shares of CME Group worth $1.66M as of Q2 2026.
CME Group was a new Bayesian Capital Management position in Q2 2026.
CME Group made up 1.06% of Bayesian Capital Management's portfolio in Q2 2026, its #17 holding.
Bayesian Capital Management first reported a position in CME Group in Q1 2018 and has held it in 10 quarters since.
Bayesian Capital Management's CME Group position peaked at $3.11M in Q4 2022.
1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.